256 related articles for article (PubMed ID: 36565198)
21. High-sensitivity cardiac troponin T: risk stratification tool in patients with symptoms of chest discomfort.
Mingels AM; Joosen IA; Versteylen MO; Laufer EM; Winkens MH; Wildberger JE; Van Dieijen-Visser MP; Hofstra L
PLoS One; 2012; 7(4):e35059. PubMed ID: 22558116
[TBL] [Abstract][Full Text] [Related]
22. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
23. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
24. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
[TBL] [Abstract][Full Text] [Related]
25. Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration.
Pasupathy S; Lindahl B; Litwin P; Tavella R; Williams MJA; Air T; Zeitz C; Smilowitz NR; Reynolds HR; Eggers KM; Nordenskjöld AM; Barr P; Jernberg T; Marfella R; Bainey K; Sodoon Alzuhairi K; Johnston N; Kerr A; Beltrame JF
Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e007880. PubMed ID: 34784229
[TBL] [Abstract][Full Text] [Related]
26. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
Ki YJ; Park S; Ha SI; Choi DH; Song H
Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
[TBL] [Abstract][Full Text] [Related]
28. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
[TBL] [Abstract][Full Text] [Related]
29. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
30. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) from the ARIAM-SEMICYUC registry: development of a score for predicting MINOCA.
Ballesteros-Ortega D; Martínez-González O; Gómez-Casero RB; Quintana-Díaz M; de Miguel-Balsa E; Martín-Parra C; López-Matamala B; Chana-García M; Alonso-Fernández MÁ; Manso-Álvarez M
Vasc Health Risk Manag; 2019; 15():57-67. PubMed ID: 30936712
[TBL] [Abstract][Full Text] [Related]
32. Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries.
Tsaban G; Peles I; Barrett O; Abramowitz Y; Shmueli H; Alnsasra H; Cafri C; Zahger D; Koifman E
Atherosclerosis; 2023 Feb; 366():8-13. PubMed ID: 36652749
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.
Velders MA; Wallentin L; Becker RC; van Boven AJ; Himmelmann A; Husted S; Katus HA; Lindholm D; Morais J; Siegbahn A; Storey RF; Wernroth L; James SK;
Am Heart J; 2015 Jun; 169(6):879-889.e7. PubMed ID: 26027627
[TBL] [Abstract][Full Text] [Related]
35. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
36. Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.
Nikorowitsch J; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143410
[TBL] [Abstract][Full Text] [Related]
37. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and prognosis of myocardial infarction in a patient without obstructive coronary artery disease during bronchoscopy: a case study and literature review.
Li M; Liu Y; Wang H
BMC Cardiovasc Disord; 2020 Apr; 20(1):185. PubMed ID: 32316919
[TBL] [Abstract][Full Text] [Related]
40. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
